Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $10.1550 (-3.38%) ($10.1550 - $10.1550) on Thu. Jun. 16, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.99% (three month average) | RSI | 48 | Latest Price | $10.1550(-3.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.9% a day on average for past five trading days. | Weekly Trend | EDIT declines -4.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(65%) IWC(59%) IWO(57%) IBUY(55%) IWM(55%) | Factors Impacting EDIT price | EDIT will decline at least -2.995% in a week (0% probabilities). VIXM(-24%) UUP(-14%) TBT(-11%) VXX(-9%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.995% (StdDev 5.99%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $11.11 | 5 Day Moving Average | $10.34(-1.79%) | 10 Day Moving Average | $11.23(-9.57%) | 20 Day Moving Average | $11.11(-8.6%) | To recent high | -52.4% | To recent low | 2.2% | Market Cap | $631m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |